UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 198

Sortiert nach

Molecular Classification of the PORTEC-3 Trial for High-Risk Endometrial Cancer: Impact on Prognosis and Benefit From Adjuvant Therapy

Journal of clinical oncology, 2020-10, Vol.38 (29), p.3388-3397

2020

Link zum Volltext

Verfügbarkeit prüfen

HER2 Testing and Clinical Decision Making in Gastroesophageal Adenocarcinoma: Guideline From the College of American Pathologists, American Society for Clinical Pathology, and the American Society of Clinical Oncology

Journal of clinical oncology, 2017-02, Vol.35 (4), p.446-464

2017

Link zum Volltext

Verfügbarkeit prüfen

Refining prognosis and identifying targetable pathways for high-risk endometrial cancer; a TransPORTEC initiative

Modern pathology, 2015-06, Vol.28 (6), p.836-844

2015

Link zum Volltext

Verfügbarkeit prüfen

Enhanced breast cancer progression by mutant p53 is inhibited by the circular RNA circ-Ccnb1

Cell death and differentiation, 2018-12, Vol.25 (12), p.2195-2208

2018

Link zum Volltext

Verfügbarkeit prüfen

Germline and somatic SMARCA4 mutations characterize small cell carcinoma of the ovary, hypercalcemic type

Nature genetics, 2014-05, Vol.46 (5), p.438-443

2014

Link zum Volltext

Verfügbarkeit prüfen

Treatment of metastatic cervical cancer: Future directions involving targeted agents

Critical reviews in oncology/hematology, 2013-03, Vol.85 (3), p.303-314

2013

Link zum Volltext

Verfügbarkeit prüfen

HER2 Status in High-Risk Endometrial Cancers (PORTEC-3): Relationship with Histotype, Molecular Classification, and Clinical Outcomes

Cancers, 2020-12, Vol.13 (1), p.44

2020

Link zum Volltext

Verfügbarkeit prüfen

Phase I and Pharmacodynamic Trial of the DNA Methyltransferase Inhibitor Decitabine and Carboplatin in Solid Tumors

Journal of clinical oncology, 2007-10, Vol.25 (29), p.4603-4609

2007

Link zum Volltext

Verfügbarkeit prüfen

Quality of adverse event reporting in phase III randomized controlled trials of breast and colorectal cancer: A systematic review

Cancer medicine (Malden, MA), 2020-07, Vol.9 (14), p.5035-5050

2020

Link zum Volltext

Verfügbarkeit prüfen

Recent and current Phase II clinical trials in endometrial cancer: review of the state of art

Expert opinion on investigational drugs, 2014-06, Vol.23 (6), p.773-792

2014

Link zum Volltext

Verfügbarkeit prüfen

Endometrial cancer: Not your grandmother's cancer

Cancer, 2016-09, Vol.122 (18), p.2787-2798

2016

Link zum Volltext

Verfügbarkeit prüfen

Endocrine therapy in endometrial cancer: An old dog with new tricks

Gynecologic oncology, 2019-04, Vol.153 (1), p.175-183

2019

Link zum Volltext

Verfügbarkeit prüfen

Targeting the protein kinase C family: are we there yet?

Nature reviews. Cancer, 2007-07, Vol.7 (7), p.554-562

2007

Link zum Volltext

Verfügbarkeit prüfen

Refining prognosis and identifying targetable pathways for high-risk endometrial cancer; a TransPORTEC initiative

Modern pathology, 2015-06, Vol.28 (6), p.836

2015

Link zum Volltext

Verfügbarkeit prüfen

Intraperitoneal chemotherapy: Hot, timely, and relevant?

Cancer, 2020-12, Vol.126 (24), p.5206-5209

2020

Link zum Volltext

Verfügbarkeit prüfen

Real-world outcomes associated with bevacizumab combined with chemotherapy in platinum-resistant ovarian Cancer

Gynecologic oncology, 2024-05, Vol.184, p.51-56

2024

Link zum Volltext

Verfügbarkeit prüfen

Prognostic refinement of NSMP high-risk endometrial cancers using oestrogen receptor immunohistochemistry

British journal of cancer, 2023-03, Vol.128 (7), p.1360-1368

2023

Link zum Volltext

Verfügbarkeit prüfen

Incidence of Brain Metastases in Nonmetastatic and Metastatic Breast Cancer: Is There a Role for Screening?

Clinical breast cancer, 2020-02, Vol.20 (1), p.e54-e64

2020

Link zum Volltext

Verfügbarkeit prüfen

HER2 Testing and Clinical Decision Making in Gastroesophageal Adenocarcinoma: Guideline From the College of American Pathologists, American Society for Clinical Pathology, and American Society of Clinical Oncology

Archives of pathology & laboratory medicine (1976), 2016-12, Vol.140 (12), p.1345-1363

2016

Link zum Volltext

Verfügbarkeit prüfen

Performance characteristics of screening strategies for Lynch syndrome in unselected women with newly diagnosed endometrial cancer who have undergone universal germline mutation testing

Cancer, 2014-12, Vol.120 (24), p.3932-3939

2014

Link zum Volltext

Verfügbarkeit prüfen

Prognostic significance of L1CAM expression and its association with mutant p53 expression in high-risk endometrial cancer

Modern pathology, 2016-02, Vol.29 (2), p.174-181

2016

Link zum Volltext

Verfügbarkeit prüfen

Molecular determinants of outcome with mammalian target of rapamycin inhibition in endometrial cancer

Cancer, 2014-02, Vol.120 (4), p.603-610

2014

Link zum Volltext

Verfügbarkeit prüfen

A phase II trial of sunitinib in women with metastatic or recurrent endometrial carcinoma: A study of the Princess Margaret, Chicago and California Consortia

Gynecologic oncology, 2014-08, Vol.134 (2), p.274-280

2014

Link zum Volltext

Verfügbarkeit prüfen

Phase II study of oral ridaforolimus in women with recurrent or metastatic endometrial cancer

Gynecologic oncology, 2014-11, Vol.135 (2), p.184-189

2014

Link zum Volltext

Verfügbarkeit prüfen

A phase II study of sunitinib in patients with locally advanced or metastatic cervical carcinoma: NCIC CTG Trial IND.184

Gynecologic oncology, 2010-02, Vol.116 (2), p.163-167

2010

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 198

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(189)
Mit Volltextzugriff
(180)

Publikationsform

Artikel
(198)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(130)
Life Sciences & Biomedicine
(118)
Humans
(94)
Female
(70)
Oncology
(53)
Middle Aged
(39)
Adult
(35)
Aged
(31)
Male
(29)
Biological And Medical Sciences
(24)
Medical Sciences
(21)
Tumors
(20)
Mutation
(16)
Aged, 80 And Over
(15)
Chemotherapy
(15)
Endometrial Cancer
(15)
Hematology, Oncology And Palliative Medicine
(14)
Animals
(13)
Prognosis
(13)
Treatment Outcome
(12)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Molecular Classification of the PORTEC-3 Trial for High-Risk Endometrial Cancer: Impact on Prognosis and Benefit From Adjuvant Therapy

HER2 Testing and Clinical Decision Making in Gastroesophageal Adenocarcinoma: Guideline From the College of American Pathologists, American Society for Clinical Pathology, and the American Society of Clinical Oncology

Refining prognosis and identifying targetable pathways for high-risk endometrial cancer; a TransPORTEC initiative

Enhanced breast cancer progression by mutant p53 is inhibited by the circular RNA circ-Ccnb1

Germline and somatic SMARCA4 mutations characterize small cell carcinoma of the ovary, hypercalcemic type

Treatment of metastatic cervical cancer: Future directions involving targeted agents

HER2 Status in High-Risk Endometrial Cancers (PORTEC-3): Relationship with Histotype, Molecular Classification, and Clinical Outcomes

Phase I and Pharmacodynamic Trial of the DNA Methyltransferase Inhibitor Decitabine and Carboplatin in Solid Tumors

Quality of adverse event reporting in phase III randomized controlled trials of breast and colorectal cancer: A systematic review

Recent and current Phase II clinical trials in endometrial cancer: review of the state of art

Endometrial cancer: Not your grandmother's cancer

Endocrine therapy in endometrial cancer: An old dog with new tricks

Targeting the protein kinase C family: are we there yet?

Refining prognosis and identifying targetable pathways for high-risk endometrial cancer; a TransPORTEC initiative

Intraperitoneal chemotherapy: Hot, timely, and relevant?

Real-world outcomes associated with bevacizumab combined with chemotherapy in platinum-resistant ovarian Cancer

Prognostic refinement of NSMP high-risk endometrial cancers using oestrogen receptor immunohistochemistry

Incidence of Brain Metastases in Nonmetastatic and Metastatic Breast Cancer: Is There a Role for Screening?

HER2 Testing and Clinical Decision Making in Gastroesophageal Adenocarcinoma: Guideline From the College of American Pathologists, American Society for Clinical Pathology, and American Society of Clinical Oncology

Performance characteristics of screening strategies for Lynch syndrome in unselected women with newly diagnosed endometrial cancer who have undergone universal germline mutation testing

Prognostic significance of L1CAM expression and its association with mutant p53 expression in high-risk endometrial cancer

Molecular determinants of outcome with mammalian target of rapamycin inhibition in endometrial cancer

A phase II trial of sunitinib in women with metastatic or recurrent endometrial carcinoma: A study of the Princess Margaret, Chicago and California Consortia

Phase II study of oral ridaforolimus in women with recurrent or metastatic endometrial cancer

A phase II study of sunitinib in patients with locally advanced or metastatic cervical carcinoma: NCIC CTG Trial IND.184

Suchergebnisse filtern